Toggle Health Problems and D

Why Isn’t Everyone Supplementing with Vitamin D - LEF Jan 2016

Nice brief introduction to vitamin D

 Download the PDF from VitaminDWiki
By Life Extension Foundation
Discusses a score of diseases
"Life Extension® has been writing about the health benefits of vitamin D for many decades."
"Vitamin D dosing in the range of 5,000 to 8,000 IU each day should be taken with a meal for better absorption."


I have been a LEF subscriber for about 20 years
I first learned of the benefits of Vitamin D thru LEF
During 2015 the magazine probably averaged 3 articles/mentions of vitamin D each month
I buy my vitamin D test via LEF - they have a very low price - but have to go to a lab for the blood draw
I buy LEF Super K to get a variety of vitamin K types
    Henry Lahore, admin of VitaminDWiki

LEF References

  1. Available at: http://www.lifeextension.com/magazine/2010/1/startling-findings-about-vitamin-d-levels-in-life-extension- members/page-01. Accessed October 8, 2015.
  2. Available at: http://www.lifeextension.com/magazine/2012/ss/vitamin-d-blood-levels/page-01. Accessed October 8, 2015.
  3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin EndocrinolMetab. 2011 ;96(7): 1911-30.
  4. Wu K, Feskanich D, Fuchs CS, et al. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007;99(14): 1120-9.
  5. Edlich R, Mason SS, Chase ME, et al. Scientific documentation of the relationship of vitamin D deficiency and the development of cancer. J Environ Pathol Toxicol Oncol. 2009;28(2): 133-41.
  6. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19(7):468-83.
  7. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174-80.
  8. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340-9.
  9. Szabo B, Merkely B, Takacs I. The role of vitamin D in the development of cardiac failure. Orv Hetil.2009; 150(30): 1397-402.
  10. Gouni-Berthold I, Krone W, Berthold HK. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol. 2009;7(3):414-22.
  11. Suzuki Y, Ichiyama T, Ohsaki A, et al. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol. 2009;113(1-2):134-8.
  12. Dietrich T, Nunn M, Dawson-Hughes B, et al. Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. Am J Clin Nutr. 2005;82(3):575-80.
  13. Xia JB, Wang CZ, Ma JX, et al. Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation. Zhonghua Yi Xue Za Zhi. 2009;89(8):514-8.
  14. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. New Engl JMed. 2009;360(18):1912-4.
  15. Williams S, Heuberger R. Outcomes of vitamin D supplementation in adults who are deficient and critically ill: A Review of the Literature. Am J Ther. 2015.
    Publisher charges for PDF
  16. Vogt S, Decke S, de Las Heras Gala T, et al. Prospective association of vitamin D with frailty status and all-cause mortality in older adults: Results from the KORA-Age Study. PrevMed. 2015;73:40-6.
  17. Lo Gullo A, Mandraffino G, Bagnato G, et al. Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number. PLoS One. 2015;10(8):e0134602.
  18. Moraes RB, Friedman G, Wawrzeniak IC, et al. Vitamin D deficiency is independently associated with mortality among critically ill patients. Clinics (Sao Paulo). 2015;70(5):326-32.
  19. Dickerson RN, Berry SC, Ziebarth JD, et al. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness. Nutrition. 2015;31(10):1219-23.
  20. Brook K, Camargo CA, Christopher KB, et al. Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Ann Intensive Care. 2015;5(1):23.
  21. Higgins DM, Wischmeyer PE, Queensland KM, et al. Relationship of vitamin D deficiency to clinical outcomes in critically ill patients. JPEN J Parenter Enteral Nutr. 2012;36(6):713-20.
  22. Zajic P, Amrein K. Vitamin D deficiency in the ICU: a systematic review. Minerva Endocrinol. 2014;39(4):275-87.
  23. Available at: http://www.cdc.gov/stroke/facts.htm. Accessed October 8, 2015.
  24. Available at: http://www.uhnj.org/stroke/stats.htm. Accessed October 8, 2015.
  25. Available at: http://www.ninds.nih.gov/disorders/stroke/stroke rehabilitation.htm. Accessed October 8, 2015.
  26. Available at: http://consumer.healthday.com/cardiovascular-health-information-20/misc-stroke-related-heart-news-360 /low-vitamin-d-levels-in-stroke-survivors-a-bad-sign-study-finds-696093.html. Accessed October 8, 2015.
  27. Turetsky A, Goddeau RP, Jr., Henninger N. Low serum vitamin D is independently associated with larger lesion volumes afterischemic stroke. JStroke Cerebrovasc Dis. 2015;24(7):1555-63.
  28. Park KY, Chung PW, Kim YB, et al. Serum vitamin D status as a predictor of prognosis in patients withacute ischemic stroke. Cerebrovasc Dis. 2015;40(1-2):73-80.
  29. Majumdar V, Prabhakar P, Kulkarni GB, et al. Vitamin D status, hypertension and ischemic stroke: a clinical perspective. J Hum Hypertens. 2015;29(11):669-74.
  30. Hartog JW, Voors AA, Schalkwijk CG, et al. Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur Heart J. 2007;28(23):2879-85.
  31. Xu W, Qiu C, Winblad B, et al. The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes. 2007;56(1):211-6.
  32. Noto H, Osame K, Sasazuki T, et al. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications. 2010;24(5):345-53.
  33. Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. DiabetolMetab Syndr. 2013;5(1):8.
  34. Oh YS, Jun HS. Role of bioactive food components in diabetes prevention: effects on Beta-cell function and preservation. Nutr Metab Insights. 2014;7:51-9.
  35. Yang Z, Liu F, Qu H, et al. 1, 25(OH)2D3 protects beta cell against high glucose-induced apoptosis through mTOR suppressing. Mol Cell Endocrinol. 2015;414:111-9.
  36. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343(13):938-52.
  37. Available at: http://www.healthline.com/health/multiple-sclerosis/facts-statistics-infographic. Accessed October 13, 2015.
  38. Mokry LE, Ross S, Ahmad OS, et al. Vitamin D and risk of multiple sclerosis: a mendelian randomization study. PLoS Med. 2015;12(8):e1001866.
  39. Available at: https://clinicaltrials.gov/ct2/show/study/NCT01285401?term=NCT01285401&rank=1. Accessed October 13, 2015.
  40. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain. 2009;132(Pt 5):1146-60.
  41. Guo Y, Xu F, Lu T, et al. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38(7):904-10.
  42. Eder K, Baffy N, Falus A, et al. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58(11):727-36.
  43. Duggan C, de Dieu Tapsoba J, Mason C, et al. Effect of vitamin D3 supplementation in combination with weight loss on inflammatory biomarkers in postmenopausal women: a randomized controlled trial. Cancer PrevRes (Phila). 2015;8(7):628-35.
  44. McGrath J. Does ‘imprinting’ with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses. 2001;56(3):367-71.
  45. Morales E, Julvez J, Torrent M, et al. Vitamin D in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology. 2015;26(4):458-65.
  46. Hawes JE, Tesic D, Whitehouse AJ, et al. Maternal vitamin D deficiency alters fetal brain development in the BALB/c mouse. Behav Brain Res. 2015;286:192-200.
  47. Cui X, Pertile R, Liu P, et al. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience. 2015;304:90-100.
  48. Brunvand L, Quigstad E, Urdal P, et al. Vitamin D deficiency and fetal growth. Early Hum Dev. 1996;45(1-2):27-33.
  49. Kesby JP, Cui X, Burne TH, et al. Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia. Front CellNeurosci. 2013;7:111.
  50. Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab. 2014;99(10):3863-72.
  51. Shivakumar V, Kalmady SV, Amaresha AC, et al. Serum vitamin D and hippocampal gray matter volume in schizophrenia. Psychiatry Res. 2015;233(2):175-9.
  52. Yuksel RN, Altunsoy N, Tikir B, et al. Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Ther Adv Psychopharmacol. 2014;4(6):268-75.
  53. Available at: https://www.washingtonpost.com/blogs/fact-checker/wp/2013/10/23/does-the-united-states-have-128- trillion-in-unfunded-liabilities. Accessed October 13, 2015.

Attached files

ID Name Comment Uploaded Size Downloads
6242 Why Isn’t Everyone Supplementing.pdf PDF 2016 admin 12 Dec, 2015 20:00 468.31 Kb 1149